Tadayoni, Ramin

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

Spaide, R. F., Jaffe, G. J., Sarraf, D., Freund, K. B., Sadda, S. R., Staurenghi, G., Waheed, N. K., Chakravarthy, U., Rosenfeld, P. J., Holz, F. G., et al. (2020) · Ophthalmology

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 824

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

Heier, J. S., Khanani, A. M., Quezada Ruiz, C., Basu, K., Ferrone, P. J., Brittain, C., Figueroa, M. S., Lin, H., Holz, F. G., Patel, V., et al. (2022) · The Lancet

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 785

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Heier, J. S., Lad, E. M., Holz, F. G., Rosenfeld, P. J., Guymer, R. H., Boyer, D., Grossi, F., Baumal, C. R., Korobelnik, J.-F., Slakter, J. S., et al. (2023) · The Lancet

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 520

Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab

Monés, J., Srivastava, S. K., Jaffe, G. J., Tadayoni, R., Albini, T. A., Kaiser, P. K., Holz, F. G., Korobelnik, J.-F., Kim, I. K., Pruente, C., et al. (2021) · Ophthalmology

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 351

A Review of Deep Learning-Based Information Fusion Techniques for Multimodal Medical Image Classification

Li, Y., El Habib Daho, M., Conze, P.-H., Zeghlache, R., Le Boité, H., Tadayoni, R., Cochener, B., Lamard, M., & Quellec, G. (2024) · Computers in Biology and Medicine

Multimodal Machine Learning ApplicationsAdvanced Image Fusion Techniques

Cited by 274

Large language models and their impact in ophthalmology

Betzler, B. K., Chen, H., Cheng, C.-Y., Lee, C. S., Ning, G., Song, S. J., Lee, A. Y., Kawasaki, R., van Wijngaarden, P., Grzybowski, A., et al. (2023) · The Lancet Digital Health

Artificial Intelligence in Healthcare and EducationOphthalmology and Visual Health Research

Cited by 161

Causes of unsuccessful ranibizumab treatment in exudative age-related macular degeneration in clinical settings

Cohen, S. Y., Oubraham, H., Uzzan, J., Dubois, L., & Tadayoni, R. (2012) · Retina

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 61

A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration

Jackson, T. L., Slakter, J., Buyse, M., Wang, K., Dugel, P. U., Wykoff, C. C., Boyer, D. S., Gerometta, M., Baldwin, M. E., Price, C. F., et al. (2023) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 55

Treatment of uveitis by in situ administration of ex vivo–activated polyclonal regulatory T cells

Grégoire, S., Terrada, C., Martin, G. H., Fourcade, G., Baeyens, A., Marodon, G., Fisson, S., Billiard, F., Lucas, B., Tadayoni, R., et al. (2016) · The Journal of Immunology

T-cell and B-cell ImmunologyOcular Diseases and Behçet’s Syndrome

Cited by 33